Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cajal Neuroscience
Seattle, Washington, United Statescajalneuro.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Preclinical
01
Overview
Cajal Neuroscience has developed a proprietary drug discovery platform that combines high-throughput microscopy, advanced functional genomics, and multiomics analyses to identify novel therapeutic targets in neurodegenerative disease. The company has raised $96 million in Series A funding and established partnerships to advance antisense oligonucleotide therapies toward IND-enabling studies. No clinical results have been published yet; most programs are preclinical or approaching IND-enabling milestones.
- Therapeutic areas
- Neurology
- Modalities
- Antisense oligonucleotides (ASOs)Small moleculesMulti-modal approaches leveraging functional genomics and multi-omics analyses
- Industry
- Biotech
02
Partnerships
Creyon Bio – collaboration on antisense oligonucleotide therapeutics for multiple neurodegenerative diseases.Bristol Myers Squibb – investor/partner role in financing round.
Beyond the preview
Go deeper on Cajal Neuroscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cajal Neuroscience.